Benzodiazepine use in patients with chronic pain in an interdisciplinary pain rehabilitation program

Julie L. Cunningham, Julia R. Craner, Michele M. Evans, W. Michael Hooten

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objectives: In the context of widespread opioid use, increased emphasis has been placed on the potentially deleterious effects of concurrent benzodiazepine (BZD) and opioid use. Although use of opioids in chronic pain has been a major focus, BZD use is equally concerning. Thus, the primary aim of this study was to determine the associations between BZD and opioid use in adults with chronic pain upon admission to an outpatient interdisciplinary pain rehabilitation (IPR) program. Methods: The study cohort involved 847 consecutive patients admitted to a 3-week outpatient IPR program from January 2013 through December 2014. Study variables included baseline demographic and clinical characteristics, Center for Epidemiologic Studies-Depression Scale, Pain Catastrophizing Scale, and the pain severity subscale of the Multidimensional Pain Inventory. Results: Upon admission, 248 (29%) patients were taking BZDs. Patients using BZDs were significantly more likely to use opioids and to be female. Additionally, patients using BZDs had significantly greater depression, pain catastrophizing, and pain severity scores. In univariable logistic regression analysis, opioid use, female sex, and greater scores of depression, pain catastrophizing, and pain severity were significantly associated with BZD use. In multivariable logistic regression analysis adjusted for age, sex, pain duration, opioid use, depression, pain catastrophizing, and pain severity, only female sex and greater depression scores were significantly associated with BZD use. Discussion: Among patients participating in an outpatient IPR program, female sex and greater depression scores were associated with BZD use. Results identify a high prevalence of BZD use in patients with chronic pain and reinforce the need to weigh the risks versus benefits when prescribing in this patient population.

Original languageEnglish (US)
Pages (from-to)311-317
Number of pages7
JournalJournal of Pain Research
Volume10
DOIs
StatePublished - Feb 9 2017

Fingerprint

Benzodiazepines
Chronic Pain
Rehabilitation
Opioid Analgesics
Pain
Catastrophization
Depression
Outpatients
Logistic Models
Regression Analysis
Epidemiologic Studies
Cohort Studies
Demography
Equipment and Supplies
Population

Keywords

  • Benzodiazepine
  • Chronic pain
  • Opioid
  • Pain rehabilitation

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Benzodiazepine use in patients with chronic pain in an interdisciplinary pain rehabilitation program. / Cunningham, Julie L.; Craner, Julia R.; Evans, Michele M.; Hooten, W. Michael.

In: Journal of Pain Research, Vol. 10, 09.02.2017, p. 311-317.

Research output: Contribution to journalArticle

Cunningham, Julie L. ; Craner, Julia R. ; Evans, Michele M. ; Hooten, W. Michael. / Benzodiazepine use in patients with chronic pain in an interdisciplinary pain rehabilitation program. In: Journal of Pain Research. 2017 ; Vol. 10. pp. 311-317.
@article{a76663f8d61143d78866d396d5912d74,
title = "Benzodiazepine use in patients with chronic pain in an interdisciplinary pain rehabilitation program",
abstract = "Objectives: In the context of widespread opioid use, increased emphasis has been placed on the potentially deleterious effects of concurrent benzodiazepine (BZD) and opioid use. Although use of opioids in chronic pain has been a major focus, BZD use is equally concerning. Thus, the primary aim of this study was to determine the associations between BZD and opioid use in adults with chronic pain upon admission to an outpatient interdisciplinary pain rehabilitation (IPR) program. Methods: The study cohort involved 847 consecutive patients admitted to a 3-week outpatient IPR program from January 2013 through December 2014. Study variables included baseline demographic and clinical characteristics, Center for Epidemiologic Studies-Depression Scale, Pain Catastrophizing Scale, and the pain severity subscale of the Multidimensional Pain Inventory. Results: Upon admission, 248 (29{\%}) patients were taking BZDs. Patients using BZDs were significantly more likely to use opioids and to be female. Additionally, patients using BZDs had significantly greater depression, pain catastrophizing, and pain severity scores. In univariable logistic regression analysis, opioid use, female sex, and greater scores of depression, pain catastrophizing, and pain severity were significantly associated with BZD use. In multivariable logistic regression analysis adjusted for age, sex, pain duration, opioid use, depression, pain catastrophizing, and pain severity, only female sex and greater depression scores were significantly associated with BZD use. Discussion: Among patients participating in an outpatient IPR program, female sex and greater depression scores were associated with BZD use. Results identify a high prevalence of BZD use in patients with chronic pain and reinforce the need to weigh the risks versus benefits when prescribing in this patient population.",
keywords = "Benzodiazepine, Chronic pain, Opioid, Pain rehabilitation",
author = "Cunningham, {Julie L.} and Craner, {Julia R.} and Evans, {Michele M.} and Hooten, {W. Michael}",
year = "2017",
month = "2",
day = "9",
doi = "10.2147/JPR.S123487",
language = "English (US)",
volume = "10",
pages = "311--317",
journal = "Journal of Pain Research",
issn = "1178-7090",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Benzodiazepine use in patients with chronic pain in an interdisciplinary pain rehabilitation program

AU - Cunningham, Julie L.

AU - Craner, Julia R.

AU - Evans, Michele M.

AU - Hooten, W. Michael

PY - 2017/2/9

Y1 - 2017/2/9

N2 - Objectives: In the context of widespread opioid use, increased emphasis has been placed on the potentially deleterious effects of concurrent benzodiazepine (BZD) and opioid use. Although use of opioids in chronic pain has been a major focus, BZD use is equally concerning. Thus, the primary aim of this study was to determine the associations between BZD and opioid use in adults with chronic pain upon admission to an outpatient interdisciplinary pain rehabilitation (IPR) program. Methods: The study cohort involved 847 consecutive patients admitted to a 3-week outpatient IPR program from January 2013 through December 2014. Study variables included baseline demographic and clinical characteristics, Center for Epidemiologic Studies-Depression Scale, Pain Catastrophizing Scale, and the pain severity subscale of the Multidimensional Pain Inventory. Results: Upon admission, 248 (29%) patients were taking BZDs. Patients using BZDs were significantly more likely to use opioids and to be female. Additionally, patients using BZDs had significantly greater depression, pain catastrophizing, and pain severity scores. In univariable logistic regression analysis, opioid use, female sex, and greater scores of depression, pain catastrophizing, and pain severity were significantly associated with BZD use. In multivariable logistic regression analysis adjusted for age, sex, pain duration, opioid use, depression, pain catastrophizing, and pain severity, only female sex and greater depression scores were significantly associated with BZD use. Discussion: Among patients participating in an outpatient IPR program, female sex and greater depression scores were associated with BZD use. Results identify a high prevalence of BZD use in patients with chronic pain and reinforce the need to weigh the risks versus benefits when prescribing in this patient population.

AB - Objectives: In the context of widespread opioid use, increased emphasis has been placed on the potentially deleterious effects of concurrent benzodiazepine (BZD) and opioid use. Although use of opioids in chronic pain has been a major focus, BZD use is equally concerning. Thus, the primary aim of this study was to determine the associations between BZD and opioid use in adults with chronic pain upon admission to an outpatient interdisciplinary pain rehabilitation (IPR) program. Methods: The study cohort involved 847 consecutive patients admitted to a 3-week outpatient IPR program from January 2013 through December 2014. Study variables included baseline demographic and clinical characteristics, Center for Epidemiologic Studies-Depression Scale, Pain Catastrophizing Scale, and the pain severity subscale of the Multidimensional Pain Inventory. Results: Upon admission, 248 (29%) patients were taking BZDs. Patients using BZDs were significantly more likely to use opioids and to be female. Additionally, patients using BZDs had significantly greater depression, pain catastrophizing, and pain severity scores. In univariable logistic regression analysis, opioid use, female sex, and greater scores of depression, pain catastrophizing, and pain severity were significantly associated with BZD use. In multivariable logistic regression analysis adjusted for age, sex, pain duration, opioid use, depression, pain catastrophizing, and pain severity, only female sex and greater depression scores were significantly associated with BZD use. Discussion: Among patients participating in an outpatient IPR program, female sex and greater depression scores were associated with BZD use. Results identify a high prevalence of BZD use in patients with chronic pain and reinforce the need to weigh the risks versus benefits when prescribing in this patient population.

KW - Benzodiazepine

KW - Chronic pain

KW - Opioid

KW - Pain rehabilitation

UR - http://www.scopus.com/inward/record.url?scp=85012113075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012113075&partnerID=8YFLogxK

U2 - 10.2147/JPR.S123487

DO - 10.2147/JPR.S123487

M3 - Article

VL - 10

SP - 311

EP - 317

JO - Journal of Pain Research

JF - Journal of Pain Research

SN - 1178-7090

ER -